The 2020 National Alzheimer's Virtual Summit

The 2020 National Alzheimer's Virtual Summit is October 19-21. More details and registration coming soon!



The National Alzheimer’s Summit will once again bring together leading policy experts, researchers, global industry leaders, providers, brand managers, individuals living with Alzheimer’s, advocates and caregivers to accelerate a cure through collaboration, mobilization and the health system change needed to ensure a brain healthy future for all communities.  This content rich convening will take place virtually and will include engaging town halls that bring together national collaborators and a night of inspiration with the 7th Annual Trish Vradenburg Be Brain Powerful® Dinner. For more information email

2020 Summit Themes 

  • Early Intervention: We will focus on strategies for developing proactive brain health across the lifespan and engage consumers, providers and policymakers to create an optimal system of brain health. 
  • Advancing Health Equity and Access: We will focus on accelerating equitable access to innovations in brain health for communities of color and women who have faced systemic discrimination and racism when accessing healthcare services and research. 
  • Accelerating Treatments and Research: We will underscore the innovation happening across the Alzheimer’s research community, from patient and caregiver centered engagement to drug development.
  • Amplifying the Voice of People Living with the Disease: We will look at what matters most to people living with the disease and explore how the needs and preferences of patients and caregivers can be prioritized in research, policymaking, and drug development.

October 20-21, 2020: Dynamic Town Halls

UsA2 will host 4 town halls that bring together partners and advocates from across the country for conversations on the multidimensional impacts of Alzheimer’s on society. From the impacts of systemic racism and COVID19 on the dementia community to speeding treatments, these conversations will be result in urgent calls to action for a healthier and more equitable future.


Building a Movement Across the Life Span to Prevent Dementia

Evidence points to an exciting opportunity for individuals to reduce dementia risk by modifying lifestyle and other health factors across their lifetime. We now know that dementia is interconnected with other conditions, including heart disease and diabetes and with the social determinants of health such as income insecurity. The coalescence of these factors translates into higher impacts of Alzheimer’s on communities of color and women and demand a comprehensive approach to brain health. Join experts and advocates for an action-oriented conversation about promoting access to brain health across the lifespan.

The key question explored: How do we build a multi-sector movement to reduce the prevalence of dementia by 30% or more by 2030?


No Data, No Justice: Addressing Systemic Racism in Alzheimer’s Research and Health Services

The impacts of systemic racism are being discussed more openly than ever before, from policing to COVID-19’s effects on Black, Indigenous, People of Color. This town hall will explore the role that systemic racism has played in shaping access to Alzheimer’s research and health services, from exclusionary study protocols to discrimination among investigators of color. Speakers will explore solutions for addressing the effects of racism through equity-centered research, policymaking, and infrastructure development.

The key question explored: How do we operationalize and evaluate the field’s commitment to addressing the root causes of systemic racism limiting access to Alzheimer’s research and health services?


COVID-19 and Dementia: Lessons for the Next Pandemic

The COVID-19 pandemic has had disproportionate and dangerous effects throughout the Alzheimer’s and dementia community, from increased stress and financial strain for those living with dementia and their caregivers to the disruption of critical Alzheimer’s clinical trials. This townhall will examine the far-reaching impacts of COVID-19 on the dementia community, particularly on Black and Latino families, and explore opportunities to build resiliency against the next pandemic through supportive public policies like paid family and medical leave and strengthened research infrastructure.

The key question explored: How can we build resiliency against future pandemics to protect the dementia community?


On the Path to 2025: Treatments and Diagnostics to Change the Trajectory of the Disease

This panel will take stock of the latest innovations in the drug pipeline as well as underscore the need for novel approaches to developing diagnostics that can improve diagnosis and draw more patients into clinical trials, especially patients at high risk of Alzheimer’s. The panel will underscore the need to attack the disease from all angles.

The key question explored: Will we meet our national goal of preventing and effectively treating Alzheimer's disease by 2025?